Skip to main content
SpringerLink
Log in

Acute Complications of Diabetes

  • Chapter
  • First Online:
Metabolic Disorders and Critically Ill Patients

Abstract

Incidence of diabetes grows continuously in developed and developing countries, so it is considered as an epidemic disease [1]. There are nowadays several possible criteria for diagnosing diabetes [2]: (1) clinical signs evoking diabetes associated with blood glucose level (BGL) ≥ 200 mg/dL (11.1 mmol/L) at any time of day, (2) a fasting BGL ≥ 126 mg/dL (7.0 mmol/L), (3) a 2-h postload BGL ≥ 200 mg/dL during an oral glycemia tolerance test, and (4) a plasma glycated hemoglobin (HbA1c) ≥ 6.5%. Type 1 diabetes is characterized by insulinopenia caused by an autoimmune and irreversible destruction of pancreatic ß-cells. Relative insulin deficiency and insulin resistance are the hallmarks of type 2 diabetes which is the most frequent in the world [3, 4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Ricordeau P, Weill A, Vallier N et al (2003) The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000? Diabetes Metab 29:497–504

    Article  PubMed  Google Scholar 

  2. American Diabetes Association (2017) Classification and diagnosis of diabetes. Diabetes Care 40(Suppl 1):S11–S24

    Article  Google Scholar 

  3. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32:1335–1348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Van Ness-Otunnu R, Hack F (2013) Hyperglycemic crisis. J Emerg Med 45:795–805

    Google Scholar 

  5. Lombardo F, Maggini M, Gruden G, Bruno G (2016) Temporal trend in hospitalizations for acute diabetic complications: a nationwide study, Italy, 2001-2010. PLoS One 8:e63675

    Article  Google Scholar 

  6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neils HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589

    Article  CAS  PubMed  Google Scholar 

  7. Ezeani IU, Eregie A, Ogebengbe OS (2013) Treatment outcome and prognostic indices in patients with hyperglycemic emergencies. Diabetes Metab Syndrome Obes 6:303–307

    Article  CAS  Google Scholar 

  8. Abdulrahman GO, Amphlett B, Okosiemme OE (2013) Trends in hospital admissions with diabetic ketoacidosis in Wales, 1999-2010. Diabetes Res Clin Pract 100:e7–10

    Article  CAS  PubMed  Google Scholar 

  9. Wang J, Williams DE, Narayan KM et al (2006) Declining death rates from hyperglycemic crisis among adults with diabetes, U.S., 1985-2002. Diabetes Care 29:2018–2022

    Article  PubMed  Google Scholar 

  10. Barski L, Nevzorov R, Rabaev E et al (2012) Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care. Isr Med Assoc 14:299–303

    Google Scholar 

  11. Savage MW, Dhatariya KK, Kilvert A et al (2011) Diabetes UK position statements and care recommendations. Joint british diabetes societies guideline for the management of diabetic ketoacidosis. Diabet Med 28:508–515

    Article  CAS  PubMed  Google Scholar 

  12. Kraut JA, Kurtz I (2005) Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 45:978–993

    Article  CAS  PubMed  Google Scholar 

  13. Wachtel TJ, Tetu-Mouradjian LM, Goldman DL et al (1991) Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island. J Gen Intern Med 6:495–502

    Article  CAS  PubMed  Google Scholar 

  14. Piniés JA, Cairo G, Gaztambide S et al (1994) Course and prognosis of 132 patients with diabetic non ketotic hyperosmolar state. Diabete Metab 20:43–48

    PubMed  Google Scholar 

  15. English P, Williams G (2004) Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Postgrad Med J 80:253–261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Yang L, Zhao J, Milutinovic PS et al (2007) Anesthetic properties of the ketone bodies beta-hydroxybutyric acid and acetone. Anesth Analg 105:673–679

    Article  CAS  PubMed  Google Scholar 

  17. Spasovski G, Vanholder R, Allolio R et al (2014) Hyponatraemia guideline development group. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med 40:320–331

    Article  PubMed  Google Scholar 

  18. Weinert LS, Scheffel RS, Severo MD et al (2012) Precipitating factors of diabetic ketoacidosis at a public hospital in a middle-income country. Diabetes Res Clin Pract 96:29–34

    Article  PubMed  Google Scholar 

  19. Musey VC, Lee JK, Crawford R et al (1995) Diabetes in urban African-Americans. I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care 18:483–489

    Article  CAS  PubMed  Google Scholar 

  20. Narins RG, Kupin W, Faber MD, Goodkin DA, Dunfee DP (1995) Pathophysiology, classification, and therapy of acid-base disturbances. In: Arieff AI, DeFronzo RA (eds) Fluid, electrolyte and acid-base disorders. Churchill Livingstone, New York, pp 105–198

    Google Scholar 

  21. Megarbane B, Marsanne C, Meas T et al (2007) Acute lower limb ischemia is a frequent complication of severe diabetic hyperosmolarity. Diabetes Metab 33:148–152

    Article  CAS  PubMed  Google Scholar 

  22. Kamel KS, Halperin ML (2015) Acid-base problems in diabetic ketoacidosis. N Engl J Med 372:546–554

    Article  PubMed  Google Scholar 

  23. Figge J, Jabor A, Kazda A, Fencl V (1998) Anion gap and hypoalbuminemia. Crit Care Med 26:1807–1810

    Article  CAS  PubMed  Google Scholar 

  24. Emmett M (2006) Anion-gap interpretation: the old and the new. Nat Clin Pract 2:4–8

    Article  Google Scholar 

  25. Stewart PA (1978) Independent and dependent variables of acid-base control. Resp Physiol 33:9–26

    Article  CAS  Google Scholar 

  26. Cox K, Cocchi MN, Salciccioli JD, Carney E, Howell M, Donnino MX (2012) Prevalence and significance of lactic acidosis in diabetic ketoacidosis. J Crit Care 27:132–137

    Article  CAS  PubMed  Google Scholar 

  27. Adrogue HJ, Madias NE (1995) Mixed acid-base disorders. In: Jacobson HR, Striker GE, Klarh S (eds) The principles and practice of nephrology, 2nd edn. Mosby-Year Book, St Louis, pp 953–962

    Google Scholar 

  28. Orban JC, Giunti C, Levraut J et al (2003) Metformin-associated lactic acidosis remains a serious complication of metformin therapy. Ann Fr Anesth Reanim 22:461–465

    Article  CAS  PubMed  Google Scholar 

  29. Mahler SA, Conrad SA, Wang H, Arnold TC (2011) Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med 29:670–674

    Article  PubMed  Google Scholar 

  30. Nyenwe EA, Kitabchi AE (2016) The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism 65:507–521

    Article  CAS  PubMed  Google Scholar 

  31. Taylor D, Durward A, Tibby SM et al (2006) The influence of hyperchloraemia on acid base interpretation in diabetic ketoacidosis. Intensive Care Med 32:295–301

    Article  CAS  PubMed  Google Scholar 

  32. Liu P, Jeng C (2004) Case report - severe hypophosphatemia in a patient with diabetic ketoacidosis and acute respiratory failure. J Chin Med Assoc 76:355–359

    Google Scholar 

  33. Misra S, Oliver NS (2015) Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabet Med 32:14–23

    Article  CAS  PubMed  Google Scholar 

  34. Schwab TM, Hendey GW, Soliz TC (1999) Screening for ketonemia in patients with diabetes. Ann Emerg Med 34:342–346

    Article  CAS  PubMed  Google Scholar 

  35. Arora S, Probst MA, Agy C, Menchine M (2011) Point-of-care beta-hydroxybutyrate testing for assessing diabetic ketoacidosis severity prior to treatment in the emergency department. Diabetes Res Clin Pract 94:e86–e88

    Article  CAS  PubMed  Google Scholar 

  36. Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM (2008) Can serum betahydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care 4:643–647

    Article  Google Scholar 

  37. Hillier TA, Abbott RD, Barrett EJ (1999) Hyponatremia evaluating the correction factor for hyperglycemia. Am J Med 106:399–404

    Article  CAS  PubMed  Google Scholar 

  38. Katz MA (1973) Hyperglycemia-induced hyponatremia—calculation of expected serum sodium depression. N Engl J Med 289:843–844

    Article  CAS  PubMed  Google Scholar 

  39. Orban JC, Maizière EM, Ghaddab A, Van Obberghen E, Ichai C (2014) Incidence and characteristics of acute kidney injury in severe diabetic ketoacidosis. PLoS One 9:e110925

    Article  PubMed  PubMed Central  Google Scholar 

  40. Al-Mallah M, Zuberi O, Arida M et al (2008) Positive troponin in diabetic ketoacidosis without evident acute coronary syndrome predicts adverse cardiac events. Clin Cardiol 31:67–71

    Article  PubMed  Google Scholar 

  41. Kitabchi AE, Umpierrez GE, Murphy MB et al (2006) Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29:2739–2748

    Article  CAS  PubMed  Google Scholar 

  42. Van Zyl DG, Rheeder P, Delport E (2012) Fluid management in diabetic-acidosis - Ringer's lactate versus normal saline: a randomized controlled trial. Q J Med 105:337–343

    Article  Google Scholar 

  43. Chua HR, Venkatesh B, Stachowski E et al (2012) Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care 27:138–145

    Article  CAS  PubMed  Google Scholar 

  44. Brown RS (1986) Extrarenal potassium homeostasis. Kidney Int 30:116–127

    Article  CAS  PubMed  Google Scholar 

  45. Clausen T (2010) Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam Clin Pharmacol 24:595–605

    Article  CAS  PubMed  Google Scholar 

  46. Mazer M, Chen E (2009) Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis? Ann Emerg Med 53:259–263

    Article  PubMed  Google Scholar 

  47. Fisher JN, Kitabchi AE (1983) A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 57:177–180

    Article  CAS  PubMed  Google Scholar 

  48. Maury E, Vassal T, Offenstadt G (1999) Cardiac contractility during severe ketoacidosis. N Engl J Med 341:1938

    Article  CAS  PubMed  Google Scholar 

  49. Viallon A, Zeni F, Lafond P et al (1999) Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Crit Care Med 27:2690–2693

    Article  CAS  PubMed  Google Scholar 

  50. Morris LR, Murphy MB, Kitabchi AE (1986) Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 105:836–840

    Article  CAS  PubMed  Google Scholar 

  51. Chua HR, Schneider A, Bellomo R (2011) Bicarbonate in diabetic ketoacidosis - a systematic review. Crit Care 1:23

    Google Scholar 

  52. Konstantinov NK, Rohrscheib M, Agaba EI, Dorin RI, Murata GH, Tzamaloukas AH (2015) Respiratory failure in diabetic ketoacidosis. World J Diabetes 6:1009–1023

    Article  PubMed  PubMed Central  Google Scholar 

  53. Gershengom HB, Iwashyna TJ, Cooke CR et al (2012) Variation in use of intensive care for adults with diabetic ketoacidosis. Crit Care Med 40:2009–2015

    Article  Google Scholar 

  54. Cohen RD, Woods HF (1983) Lactic acidosis revisited. Diabetes 32:181–191

    Article  CAS  PubMed  Google Scholar 

  55. UK Prospective Diabetes Study Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865

    Article  Google Scholar 

  56. Duncan AI, Koch CG, Xu M et al (2007) Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery. Anesth Analg 104:42–50

    Article  CAS  PubMed  Google Scholar 

  57. Trinkley KE, Malone DC, Nelson JA, Saseen JJ (2016) Prescribing attitudes, behaviors nd opinions regarding metformin for patients with diabetes: a focus group study. Ther Adv Chronic Dis 7:220–228

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Renda F, Mura P, Finco G, Ferrazin F, Pani L, Landoni G (2013) Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci 17(suppl):45–49

    PubMed  Google Scholar 

  59. DeFronzo R, Fleming GA, Chen K, Bisack A (2016) Metformin-associated lactic acidosis: current perspective on causes and risk. Metab Clin Exp 65:20–29

    Article  CAS  PubMed  Google Scholar 

  60. Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR (2008) Metformin, sulfonylurea, or other antidiabetic drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care 31:2086–2091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Misbin RJ, Lahn RG, Stadel BV et al (1998) Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338:265–266

    Article  CAS  PubMed  Google Scholar 

  62. Seidowsky A, Nseir S, Houdret N et al (2009) Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 37:2191–2196

    Article  CAS  PubMed  Google Scholar 

  63. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE (2010) Risk of fatal and non fatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 20:CD002967

    Google Scholar 

  64. Friesecke S, Abel P, Roser M, Felix SB, Runge S (2010) Outcome of severe lactic acidosis associated with metformin accumulation. Crit Care 14:R226

    Article  PubMed  PubMed Central  Google Scholar 

  65. Kamber N, Davis WA, Bruce DG et al (2008) Metformin and lactic acidosis in an Australian community setting: the Fremantle diabetes study. Med J Aust 188:446–449

    PubMed  Google Scholar 

  66. Kajbaf F, Lalau JD (2013) The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database. Diabetes Metab 30:345–348

    CAS  Google Scholar 

  67. Kajbaf F, Lalau JD (2013) The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis. BMC Pharmacol Toxicol 14:22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Kajbaf F, Lalau JD (2014) Mortality rate in so-called "metformin-associated lactic acidosis": a review of the data since the 1960s. Pharmacoepidemiol Drug Safe 23:1123–1127

    Article  CAS  Google Scholar 

  69. Chang CT, Chen YC, Fang JT, Huang CC (2002) Metformin-associated lactic acidosis: case reports and literature review. J Nephrol 15:398–402

    PubMed  Google Scholar 

  70. Wills BK, Bryant SM, Buckley P, Seo B (2010) Can acute overdose of metformin lead to lactic acidosis? Am J Emerg Med 28:857–861

    Article  PubMed  Google Scholar 

  71. Dell'Aglio DM, Perino LJ, Kazzi Z, Abramson J, Schwartz MD, Morgan BW (2009) Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. Ann Emerg Med 54:818–823

    Article  PubMed  Google Scholar 

  72. Boucaud-Maitre D, Ropers J, Porokhov B et al (2016) Lactic acidosis: relationship between metformin levels, lactate concentration and mortality. Diabet Med 33:1536–1154

    Article  CAS  PubMed  Google Scholar 

  73. Li L, Gopalakrishnan C, Heide-Jørgensen U et al (2017) Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK. Diabet Med 34:485–489

    Article  CAS  PubMed  Google Scholar 

  74. Orban JC, Fontaine E, Ichai C (2012) Metformin overdose: time to move on. Crit Care 16:164

    Article  PubMed  PubMed Central  Google Scholar 

  75. Protti A, Russo R, Tagliabue P et al (2010) Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication. Crit Care 14:R22

    Article  PubMed  PubMed Central  Google Scholar 

  76. El-Mir MY, Nogueira V, Fontaine E et al (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275:223–228

    Article  CAS  PubMed  Google Scholar 

  77. Madiraju AK, Erion DM, Rahimi Y et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510:542–546

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Argaud D, Roth H, Wiernsperger N et al (1993) Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes. Eur J Biochem 213:1341–1348

    Article  CAS  PubMed  Google Scholar 

  79. McCreight LJ, Bailey CJ, Pearson ER (2016) Metformin and the gastrointestinal tract. Diabetologia 59:426–435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Mirrakhimov AE, Barbaryan A, Gray A, Ayach T (2016) The role of renal replacement therapy in the management of pharmacologic poisoning. Int J Nephrol 2016:12

    Article  Google Scholar 

  81. Lalau JD, Race JM (1999) Lactic acidosis in metformin therapy. Drugs 58:55–60

    Article  CAS  PubMed  Google Scholar 

  82. Arroyo D, Melero R, Panizo N et al (2011) Metformin associated acute kidney injury and lactic acidosis. Int J Nephrol 2011:749653

    Article  PubMed  PubMed Central  Google Scholar 

  83. Stades AM, Heikens JT, Erkelens DW et al (2004) Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med 255:179–187

    Article  CAS  PubMed  Google Scholar 

  84. Callelo DP, Liu KD, Wiegand TJ et al (2015) Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med 43:1716–1730

    Article  Google Scholar 

  85. Peters N, Jay N, Barraud D et al (2008) Metformin-associated lactic acidosis in an intensive care unit. Crit Care 12:R149

    Article  PubMed  PubMed Central  Google Scholar 

  86. Emslie-Smith AM, Boyle DI, Evans JM et al (2001) Contra-indications to metformin therapy in patients with type 2 diabetes: a population-based study of adherence to prescribing guidelines. Diabet Med 18:483–488

    Article  CAS  PubMed  Google Scholar 

  87. UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853

    Article  Google Scholar 

  88. Murata GH, Duckworth WC, Shah JH et al (2004) Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes: the diabetes outcomes in veterans study (DOVES). Diabetes Res Clin Pract 65:61–67

    Article  PubMed  Google Scholar 

  89. Vinik AI, Maser RE, Mitchell BD et al (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579

    Article  PubMed  Google Scholar 

  90. Laing SP, Swerdlow AJ, Slater SD et al (1999) The British diabetic association cohort study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16:459–465

    Article  CAS  PubMed  Google Scholar 

  91. Cranston I, Lomas J, Maran A et al (1994) Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283–287

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

No conflict of interest.

Author information

Authors and Affiliations

  1. Intensive Care Unit, Hôpital Pasteur 2, 30 Voie Romaine, 06001, Nice, Cédex 1, France

    Jean-Christophe Orban & Carole Ichai

  2. IRCAN (INSERM U1081, CNRS UMR 7284), University Hospital of Nice, Nice, France

    Jean-Christophe Orban, Emmanuel Van Obberghen & Carole Ichai

Authors
  1. Jean-Christophe Orban
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanuel Van Obberghen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carole Ichai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Christophe Orban .

Editor information

Editors and Affiliations

  1. Intensive Care Unit, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, France

    Carole Ichai

  2. Intensive Care Unit, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, France

    Hervé Quintard

  3. Intensive Care Unit, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, France

    Jean-Christophe Orban

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Orban, JC., Van Obberghen, E., Ichai, C. (2018). Acute Complications of Diabetes. In: Ichai, C., Quintard, H., Orban, JC. (eds) Metabolic Disorders and Critically Ill Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-64010-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64010-5_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64008-2

  • Online ISBN: 978-3-319-64010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation